The opposite effect of tapinarof between IMQ and IL‐23 induced psoriasis mouse models
Experimental Dermatology · 2024-01 · 33 (1)
DOI: 10.1111/exd.14862 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Dermatology, online erschienen am 23.06.2023. Verfasst von Xingyu Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University,…. Hauptthemen laut MEDLINE: Psoriasis, Stilbenes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: CAMS Innovation Fund for Medical Science, National Natural Science Foundation of China.
Abstract (Originalsprache)
Tapinarof is an aryl hydrocarbon receptor (AHR) ligand which is used to treat plaque psoriasis in adults. However, the underlying mechanism is not yet fully understood. In this study, we applied two of the most studied psoriasis mouse models: topical application of imiquimod (IMQ) and subcutaneous injection of IL‐23. Although both models successfully induced psoriasis‐like lesions in mice, tapinarof had a completely opposite effect on the two models. Tapinarof decreased the expression of multiple essential cytokines involved in the pathological IL‐23/IL‐17/IL‐22 axis and ameliorated IMQ‐induced psoriatic dermatitis, inhibiting keratinocyte proliferation and abnormal differentiation. However, in the IL‐23‐injection‐model, tapinarof instead aggravated the disease. Here, tapinarof increased epidermal thickness and differentiated epidermal dysplasia in mice. Our data suggest that tapinarof may have different effects on varied types of psoriasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China.
- Institute for Six-Sector Economy, Fudan University, Shanghai, China.
- Greater Bay Area Institute of Precision Medicine (Guangzhou), School of Life Sciences, Fudan University, Shanghai, China.
- MOE Key Laboratory of Contemporary Anthropology, School of Life Sciences, Fudan University, Shanghai, China.
- Research Unit of Dissecting the Population Genetics and Developing New Technologies for Treatment and Prevention of Dermatological Diseases (2019RU058), Chinese Academy of Medical Sciences, Shanghai, China.
ORCID-Profile: Jiucun Wang, Jingjing Xia
Förderung
- CAMS Innovation Fund for Medical Science
- National Natural Science Foundation of China
Zitieren
APA
Zhu, X., Han, R., Tian, X., Hochgerner, M., Li, H., Wang, J., & Xia, J. (2024). The opposite effect of tapinarof between IMQ and IL‐23 induced psoriasis mouse models. Experimental Dermatology, 33(1). https://doi.org/10.1111/exd.14862
Vancouver
Zhu X, Han R, Tian X, Hochgerner M, Li H, Wang J, et al. The opposite effect of tapinarof between IMQ and IL‐23 induced psoriasis mouse models. Experimental Dermatology. 2024;33(1). doi:10.1111/exd.14862
BibTeX
@article{Zhu2024,
author = {Zhu, Xingyu and Han, Ruomei and Tian, Xiaoxue and Hochgerner, Mathias and Li, Hui and Wang, Jiucun and Xia, Jingjing},
title = {The opposite effect of tapinarof between IMQ and IL‐23 induced psoriasis mouse models},
journal = {Experimental Dermatology},
year = {2024},
volume = {33},
number = {1},
doi = {10.1111/exd.14862}
}
EUVIMED